Athyrium Opportunities Fund III (AOF III)

Athyrium Opportunities Fund III1

Company Description Initial Investment Date
CareMax Multi-Specialty Provider Group February 2017
Alvogen Specialty Generics April 2017
Teladoc Telemedicine Platform July 2017
OB Hospitalist Group OB Hospitalist Services August 2017
DuPage Medical Group Multi-Specialty Physician Group August 2017
Biora Therapeutics, Inc. Prenatal Women's Health Genetics and Gastrointestinal / Inflammatory Bowel Disease Precision Medicine October 2017
Societal CDMO Post-Operative Pain / Contract Development and Manufacturing Organization November 2017
PharMerica Institutional and Specialty Pharmacy Services Provider December 2017
Centinel Spine Spine Total Disc Replacement and Integrated Interbody Systems December 2017
OptiNose XHANCE / Exhalation Delivery Systems (EDS) platform December 2017
Veloxis Envarsus XR / MeltDose Technology February 2018
Biom'Up HEMOBLAST Bellows / Hemostatic Products February 2018
Aqua Dermatology Dermatology Provider Group May 2018
VIVUS, Inc. Pancreaze and Qsymia June 2018
TESARO, Inc. Zejula / Oncology June 2018
Sound Inpatient Physicians, Inc. Hospitalist Services June 2018
Agendia NV Breast Cancer Diagnostics July 2018
Amryt Pharma Orphan Pharmaceuticals July 2018
naviHealth, Inc. Post-Acute Care Management August 2018
Kala Pharmaceuticals, Inc. INVELTYS / Ophthalmic Pharmaceuticals October 2018
Dermira, Inc. QBREXZA / Dermatology December 2018
Portola Pharmaceuticals, Inc. Hematology Pharmaceuticals February 2019
Secura Bio FARYDAK / Oncology March 2019
Longevity Health Founders LLC (Longevity Health Plan) Institutional Special Needs Plan March 2019
ArisGlobal HCIT July 2019
BW NHHC HoldCo Inc. (Elara Caring) Home Health Services Platform October 2019
Upstream Rehabilitation Physical Therapy Services Provider October 2019
InnovaCare Health Integrated Payor and Provider Organization December 2019
Clario HCIT February 2020
Leon Health Systems, LLC Integrated Delivery System October 2020
BioCryst Pharmaceuticals, Inc. ORLADEYO / rare disease December 2020

1. This table lists all investments made by the Athyrium Opportunities Fund III.